Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64−0.00 (-0.73%)
Close on Oct 19, 2026Market cap $522.65KP/E –Yield –
Nexentis Technologies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Nexentis Technologies's free cash flow for the twelve months ending Dec 31, 2022 was -$5.15M. For fiscal 2025 it was -$3.82M. The highest annual figure on record is -$509.03K in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.82M | – |
| FY2022 | Dec 31, 2022 | -$5.15M | – |
| FY2021 | Dec 31, 2021 | -$4.18M | – |
| FY2019 | Dec 31, 2019 | -$1.27M | – |
| FY2018 | Dec 31, 2018 | -$509.03K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$540.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.49M | – |
| Q4 FY2022 | Dec 31, 2022 | -$974.52K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.79M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.28M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$975.79K | – |
| Q4 FY2019 | Dec 31, 2019 | -$383.40K | – |
See a number that looks wrong?